Cargando…
Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells
The invasive capacity of GBM is one of the key tumoral features associated with treatment resistance, recurrence, and poor overall survival. The molecular machinery underlying GBM invasiveness comprises an intricate network of signaling pathways and interactions with the extracellular matrix and hos...
Autores principales: | Velásquez, Carlos, Mansouri, Sheila, Mora, Carla, Nassiri, Farshad, Suppiah, Suganth, Martino, Juan, Zadeh, Gelareh, Fernández-Luna, José L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699388/ https://www.ncbi.nlm.nih.gov/pubmed/31467533 http://dx.doi.org/10.1155/2019/1740763 |
Ejemplares similares
-
Special issue: a contemporary landscape of the clinical and biological research in neurofibromatosis type 1
por: Suppiah, Suganth, et al.
Publicado: (2020) -
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
por: Karimi, Shirin, et al.
Publicado: (2020) -
The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
por: Karimi, Shirin, et al.
Publicado: (2019) -
SHH PATHWAY ACTIVATION DRIVES MALIGNANT TRANSFORMATION IN A SUBSET OF MPNSTS AND IS A POTENTIAL THERAPEUTIC TARGET
por: Suppiah, Suganth, et al.
Publicado: (2023) -
Dendritic cell vaccines for high-grade gliomas
por: Eagles, Matthew E, et al.
Publicado: (2018)